J. I. Lai, W. S. Wang “Acute Hemolysis after Receiving Oxaliplatin Treatment: A Case Report and Literature Review,” Pharmacy World & Science, Vol. 31, No. 5, 2009, pp. 538-541. doi:10.1007/s11096-009-9313-0

has been cited by the following article:

• TITLE: Recurrent Oxaliplatin-Induced Immune Hemolytic Anemia by Chemotherapy for Metastatic Colon Cancer: A Case Report

  AUTHORS: Sandrine Oziel-Taieb, Renaud Sabatier, Marine Gilabert, Sylvain Garciaz, Pauline Ries, Slimane Dermeche, Jean-Luc Raoul

  KEYWORDS: Oxaliplatine; Hemolysis; Auto-Immune; Colorectal Cancer

  JOURNAL NAME: Journal of Cancer Therapy, Vol.4 No.1, February 17, 2013

  ABSTRACT: We report herein the case of a 55-year-old man who presented an acute hemolysis following a 6th cycle of FOLFOX regimen for a metastatic colorectal cancer; this patient had previously received 12 cycles in an adjuvant setting. He had presented attenuated signs during the previous cycle. This corresponded to an oxaliplatin-induced immune hemolytic anemia. This unfrequent side effect of oxaliplatin needs to be known in order to avoid severe complications.